Probiotic Therapy During Vaccination Alters Antibody Response to Simian-Human Immunodeficiency Virus Infection But Not to Commensals
AIDS Research and Human Retroviruses · 2023-05 · 39 (5) · 222-231
DOI: 10.1089/aid.2022.0123 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Research and Human Retroviruses, online erschienen am 05.05.2023. Verfasst von Andrew Wilson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Tropical Medicine, School of Medicine and Health Sciences, George Washington University, Washington, Distr…. Hauptthemen laut MEDLINE: HIV Infections, Simian Immunodeficiency Virus, HIV-1, Simian Acquired Immunodeficiency Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
The induction of robust circulating antibody titers is a key goal of HIV-1 vaccination. Probiotic supplementation is an established strategy to enhance microbiota and boost antibody responses to vaccines. A recent study tested whether oral probiotics could enhance vaccine-specific mucosal immunity by testing vaccination with and without supplementation in a Rhesus macaque Simian-Human Immunodeficiency Virus challenge model. Although supplementation was not associated with protection, the effects of probiotics on immunity after infection were not examined. To address this question, we measured antibody titers to HIV Env and commensal bacteria in plasma from the vaccination/supplementation time points as well as after Simian-Human Immunodeficiency Virus (SHIV) acquisition. We found that a trend toward lower HIV Env-specific titers in the animals given probiotics plus vaccine became greater after SHIV infection. Significantly lower Immunoglobulin (Ig) A titers were observed in animals vaccinated and supplemented compared with vaccine alone due to a delay in antibody kinetics at week 2 postinfection. We observed no difference, however, in titers to commensal bacteria during probiotic supplementation or after SHIV infection. These results suggest that probiotic supplementation may be a strategy for reducing IgA-specific HIV antibodies in the plasma, a correlate associated with increased HIV infection in the RV144 clinical trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Tropical Medicine, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia, USA.
- Division of Immunology, Tulane National Primate Research Center, Covington, Louisiana, USA.
- Department of Statistics, George Washington University, Washington, District of Columbia, USA.
- Department of Microbiology and Immunology, Scripps Biomedical Research, University of Florida, Jupiter, Florida, USA.
- Department of Surgery, Division of Surgical Outcomes and Precision Medicine Research, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Jennifer A Manuzak, Rebecca M Lynch
Förderung
- NIH HHS
- NIAID NIH HHS
- NICHD NIH HHS
Zitieren
APA
Wilson, A., Manuzak, J. A., Liang, H., Leda, A. R., Klatt, N., & Lynch, R. M. (2023). Probiotic Therapy During Vaccination Alters Antibody Response to Simian-Human Immunodeficiency Virus Infection But Not to Commensals. AIDS Research and Human Retroviruses, 39(5), 222-231. https://doi.org/10.1089/aid.2022.0123
Vancouver
Wilson A, Manuzak JA, Liang H, Leda AR, Klatt N, Lynch RM. Probiotic Therapy During Vaccination Alters Antibody Response to Simian-Human Immunodeficiency Virus Infection But Not to Commensals. AIDS Research and Human Retroviruses. 2023;39(5):222-231. doi:10.1089/aid.2022.0123
BibTeX
@article{Wilson2023,
author = {Wilson, Andrew and Manuzak, Jennifer A and Liang, Hua and Leda, Ana R and Klatt, Nichole and Lynch, Rebecca M},
title = {Probiotic Therapy During Vaccination Alters Antibody Response to Simian-Human Immunodeficiency Virus Infection But Not to Commensals},
journal = {AIDS Research and Human Retroviruses},
year = {2023},
volume = {39},
number = {5},
pages = {222--231},
doi = {10.1089/aid.2022.0123}
}
EUVIMED